Pieris Pharmaceuticals, Inc.: Platform technology company developing Anticalin proteins (engineered human lipocalins) for respiratory diseases and oncology. Recently showed Ph 1 data for data for: 1) AZN-partnered PRS-060 for moderate-to-severe asthma (targeting IL4RA through inhalation) and 2) fully-proprietary IO program PRS-343 for HER2+ solid tumors (targeting 4-1BB and HER2). Additional IO partnerships w/ Servier and Seattle Genetics.
Sector/industry:
Healthcare/Biotechnology
Characteristics:
Based in...
US - New England
Clinical Stage
Phase l or ll
Disease Space
Immuno-Oncology, Immunotherapy, Oncology, Respiratory
Finance
Pre-earnings
Industry
Biotechnology
Listing
Public, USA
Market Cap
100MM - 500MM
Therapeutic Modalities
Antibodies, Platform Technology
Website:
Profiles:
Address:
255 State Street
Boston, MA 02109
United States

Company Participants at Pieris Pharmaceuticals R&D Day

  • Stephen S. Yoder, CEO

Send Message to Request Information

Log in to download presentation, request a 1x1 meeting, view additional roadshows, and more.

Lead Programs

PRS-060

Indication Phase
IL4-Rα 1

PRS-343

Indication Phase
HER2/4-1BB 1
+ Anti-PD-L1 1

Top 10 Holders of Pieris Pharmaceuticals, Inc.

Institution OS (%) Position Mkt Val ($MM) Source Filing Date
BVF, Inc. 11.92 5,872,762 17.97 13F 2020-03-31
BVF Partners LP 11.92 5,872,762 17.97 Stakes 2020-02-14
Aquilo Capital Management LLC 11.32 5,575,530 17.06 Stakes 2020-03-31
Renaissance Technologies LLC 3.74 1,844,090 5.64 13F 2020-03-31
Corriente Advisors LLC 3.62 1,781,921 5.45 13F 2020-03-31
BlackRock Fund Advisors 3.50 1,726,278 5.28 13F 2020-03-31
Samsara Biocapital LLC 3.29 1,620,249 4.96 13F 2020-03-31
Candriam Luxembourg SCA 3.02 1,488,175 4.55 13F 2020-03-31
Tekla Capital Management LLC 2.94 1,449,269 4.43 13F 2020-03-31
Candriam Belgium SA 2.81 1,382,237 4.23 Funds 2019-12-31

Top 10 Holders of Pieris Pharmaceuticals, Inc.

Institution OS (%) Position Mkt Val ($MM) Source Filing Date
BVF Partners LP 100.00 2,907 0.01 Stakes 2020-02-14

Top 10 Holders of Pieris Pharmaceuticals, Inc.

Institution OS (%) Position Mkt Val ($MM) Source Filing Date
BVF Partners LP 100.00 3,522 0.01 Stakes 2020-02-14

Top 10 Holders of Pieris Pharmaceuticals, Inc.

Institution OS (%) Position Mkt Val ($MM) Source Filing Date
BVF Partners LP 100.00 5,000 0.02 Stakes 2020-02-14
Ownership data is sourced through FactSet.

Stock Market Data

Data is being loaded...
Data is being loaded...
Data is being loaded...
Data is being loaded...
Market Data copyright © 2020 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, RTB=Real-Time BATS BZX Price/Quote; not sourced from all markets, RTN=Real-Time NASDAQ Basic+ Price/Quote; not sourced from all markets, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.